Abstract:Aims: This investigation aimed to clarify the intricate relationship among depression, cognitive function, adverse childhood experiences (ACEs), and their combined influence on methamphetamine use disorder (MUD). Methods: Utilizing a battery of psychological tests, this study ascertained the impact of ACEs on the condition of 76 people with MUD who meet the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) criteria, aged 42.17 on average. The Iowa Gambling Task (IGT), Conners' Continuous Performance-II (CPT-II), the self-report Severity of Dependence Scale (SDS), and the Beck Depression Inventory-II (BDI-II) were used for these evaluations. Individuals involved in the study were categorized into two discrete cohorts, mild (ME) and severe (SE), based on the extent of their ACEs exposure. This study employed the PROCESS regression, the independent t-test andχ2 tests for the analysis. Results: The findings revealed notable discrepancies in the psychological consequences between the two groups with different degrees of ACEs; however, no substantial differences were observed in the demographic parameters. The SE group exhibited elevated BDI-II scores, more evident indications of MUD, and a higher degree of CPT-II cognitive perseveration. The PROCESS model revealed that cognitive perseveration moderated the impact of depression on ACEs and subjective MUD severity, explaining 20.2% of the variance. The ACEs and depression predicted 28.6% of the variance in MUD symptoms. However, no statistically significant differences were detected between the two groups regarding the parameters in the IGT-2 assessment. Conclusions: These results indicate that the interaction between cognitive and depressive factors mediates the effect of ACEs on subjective MUD severity but not on MUD symptoms. The ACEs significant impact on mental health severity perception is explained by cognitive and depressive factors. This implies that MUD treatment and rehabilitation should address cognitive dysfunction and developmental trauma.

Relationship of clinical features with metacognition and states of mind in methamphetamine-use disorder patients

Mindfulness and clinical correlates in methamphetamine use disorder

Altered spontaneous neurological activity in methamphetamine use disorders and its association with cognitive function

Disrupted brain network dynamics and cognitive functions in methamphetamine use disorder: insights from EEG microstates

Dissociation of Drug and Negative Emotional Cue Induced Attentional Bias in Individuals with Methamphetamine-Use Disorder

Features of Psychotic Symptoms in Methamphetamine Use Disorder Patients and Ketamine Use Disorder Patients: A Cross-Sectional Study

Prevalence and Risk Factors for Depressive Symptom in Methamphetamine Use Disorder

The influence of adverse childhood experiences and depression on addiction severity among methamphetamine users: exploring the role of perseveration

Impaired Social Decision-Making in Males with Methamphetamine Use Disorder.

Multidimensional 3T Structural Magnetic Resonance Imaging Study of Individuals with Methamphetamine Use Disorder: Extensive Structural Abnormalities in Frontal Cortex and Their Relationship to Cognitive Function

Reduced neural functional connectivity during working memory performance in methamphetamine use disorder

Mapping structural covariance networks of emotional withdrawal symptoms in males with methamphetamine use disorder during abstinence

Individuals with Methamphetamine Use Disorder Show Reduced Directed Exploration and Learning Rates Independent of an Aversive Interoceptive State Induction

Cognitive functions in people with mental disorders: focus on self-reflection, insight and mindwandering

Impaired Outcome Evaluation During Risky Decision-Making in Individuals with Methamphetamine Use Disorder

Psychophysiological and Self-Reported Responses in Individuals with Methamphetamine Use Disorder Exposed to Emotional Video Stimuli.

Association Between White Matter Microstructure and Cognitive Function in Patients with Methamphetamine Use Disorder.

Brain Morphometric Abnormalities and Their Associations with Affective Symptoms in Males with Methamphetamine Use Disorder During Abstinence

The Relationship Between Serum Cytokine Levels and the Degree of Psychosis and Cognitive Impairment in Patients With Methamphetamine-Associated Psychosis in Chinese Patients

Metacognitive deficits predict future levels of negative symptoms in schizophrenia controlling for neurocognition, affect recognition, and self-expectation of goal attainment

Dysfunctional feedback processing in male methamphetamine abusers: Evidence from neurophysiological and computational approaches